Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Effects of Tysabri over 12 months on multiple sclerosis (MS) related fatigue in patients with relapsing remitting multiple sclerosis (RRMS) (TYNERGY)
Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus.
Control of microglial neurotoxicity by the fractalkine receptor.
Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses.
How Does Transcranial Magnetic Stimulation Influence Glial Cells in the Central Nervous System?
Decreased NAA in Gray Matter is Correlated with Decreased Availability of Acetate in White Matter in Postmortem Multiple Sclerosis Cortex.
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
P2X7 Receptor as a Therapeutic Target.
Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach.
Is there a (host) genetic predisposition to progressive multifocal leukoencephalopathy?
Television-provoked epilepsy in children: a follow-up survey from Isfahan, Iran.
Disability profile of multiple sclerosis in New Zealand.
Pages
« first
‹ previous
…
671
672
673
674
675
676
677
678
679
…
next ›
last »